Literature DB >> 28232742

Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997-2013.

S Lehmann1,2, S Deneberg2, P Antunovic3, Å Rangert-Derolf4, H Garelius5, V Lazarevic6, K Myhr-Eriksson7, L Möllgård5, B Uggla7, A Wahlin7, L Wennström5, M Höglund1, G Juliusson6.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28232742     DOI： 10.1038/leu.2017.71

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

1.  Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.

Authors:  Jae H Park; Baozhen Qiao; Katherine S Panageas; Maria J Schymura; Joseph G Jurcic; Todd L Rosenblat; Jessica K Altman; Dan Douer; Jacob M Rowe; Martin S Tallman
Journal:  Blood       Date:  2011-06-08       Impact factor: 22.113

Review 2.  Current management of newly diagnosed acute promyelocytic leukemia.

Authors:  L Cicconi; F Lo-Coco
Journal:  Ann Oncol       Date:  2016-04-15       Impact factor: 32.976

3.  Acute promyelocytic leukaemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukaemia referral centres: a pan-Canadian epidemiological study.

Authors:  Kristjan Paulson; Anna Serebrin; Pascal Lambert; Julie Bergeron; Janeve Everett; Andrea Kew; David Jones; Salah Mahmud; Catherine Meloche; Mitchell Sabloff; Ismail Sharif; John Storring; Donna Turner; Matthew D Seftel
Journal:  Br J Haematol       Date:  2014-04-30       Impact factor: 6.998

4.  Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.

Authors:  S Lehmann; A Ravn; L Carlsson; P Antunovic; S Deneberg; L Möllgård; A Rangert Derolf; D Stockelberg; U Tidefelt; A Wahlin; L Wennström; M Höglund; G Juliusson
Journal:  Leukemia       Date:  2011-04-19       Impact factor: 11.528

5.  Treatment advances have not improved the early death rate in acute promyelocytic leukemia.

Authors:  James Scott McClellan; Holbrook E Kohrt; Steven Coutre; Jason R Gotlib; Ravindra Majeti; Ash A Alizadeh; Bruno C Medeiros
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

6.  Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.

Authors:  Alan K Burnett; Nigel H Russell; Robert K Hills; David Bowen; Jonathan Kell; Steve Knapper; Yvonne G Morgan; Jennie Lok; Angela Grech; Gail Jones; Asim Khwaja; Lone Friis; Mary Frances McMullin; Ann Hunter; Richard E Clark; David Grimwade
Journal:  Lancet Oncol       Date:  2015-09-14       Impact factor: 41.316

7.  Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

Authors:  Francesco Lo-Coco; Giuseppe Avvisati; Marco Vignetti; Christian Thiede; Sonia Maria Orlando; Simona Iacobelli; Felicetto Ferrara; Paola Fazi; Laura Cicconi; Eros Di Bona; Giorgina Specchia; Simona Sica; Mariadomenica Divona; Alessandro Levis; Walter Fiedler; Elisa Cerqui; Massimo Breccia; Giuseppe Fioritoni; Helmut R Salih; Mario Cazzola; Lorella Melillo; Angelo M Carella; Christian H Brandts; Enrica Morra; Marie von Lilienfeld-Toal; Bernd Hertenstein; Mohammed Wattad; Michael Lübbert; Matthias Hänel; Norbert Schmitz; Hartmut Link; Maria Grazia Kropp; Alessandro Rambaldi; Giorgio La Nasa; Mario Luppi; Fabio Ciceri; Olimpia Finizio; Adriano Venditti; Francesco Fabbiano; Konstanze Döhner; Michaela Sauer; Arnold Ganser; Sergio Amadori; Franco Mandelli; Hartmut Döhner; Gerhard Ehninger; Richard F Schlenk; Uwe Platzbecker
Journal:  N Engl J Med       Date:  2013-07-11       Impact factor: 91.245

8.  Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.

Authors:  Gunnar Juliusson; Petar Antunovic; Asa Derolf; Sören Lehmann; Lars Möllgård; Dick Stockelberg; Ulf Tidefelt; Anders Wahlin; Martin Höglund
Journal:  Blood       Date:  2008-11-13       Impact factor: 22.113

9.  Disparities in early death and survival in children, adolescents, and young adults with acute promyelocytic leukemia in California.

Authors:  Renata Abrahão; Raul C Ribeiro; Bruno C Medeiros; Ruth H Keogh; Theresa H M Keegan
Journal:  Cancer       Date:  2015-08-11       Impact factor: 6.921
  9 in total
  11 in total

1.  The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study.

Authors:  Mehmet Baysal; Vildan Gürsoy; Fazil Cagri Hunutlu; Buket Erkan; Ufuk Demirci; Volkan Bas; Sedanur Karaman Gulsaran; Ibrahim Ethem Pinar; Tuba Ersal; Tugcan Alp Kirkizlar; Emine Ikbal Atli; Hakki Onur Kirkizlar; Elif G Ümit; Hakan Gürkan; Vildan Ozkocaman; Fahir Ozkalemkas; Ahmet Muzaffer Demir; Ridvan Ali
Journal:  Ann Hematol       Date:  2022-02-21       Impact factor: 3.673

2.  Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia.

Authors:  Hitoshi Minamiguchi; Hiroyuki Fujita; Yoshiko Atsuta; Norio Asou; Toru Sakura; Yasunori Ueda; Masashi Sawa; Nobuaki Dobashi; Yasuhiro Taniguchi; Rikio Suzuki; Yoshihito Uchino; Akihiro Tomita; Shigehisa Tamaki; Maki Hagihara; Katsumichi Fujimaki; Masamitsu Yanada; Yoshinobu Maeda; Masako Iwanaga; Noriko Usui; Yukio Kobayashi; Shigeki Ohtake; Hitoshi Kiyoi; Itaru Matsumura; Yasushi Miyazaki; Tomoki Naoe; Akihiro Takeshita
Journal:  Ann Hematol       Date:  2020-09-02       Impact factor: 3.673

3.  A risk score based on real-world data to predict early death in acute promyelocytic leukemia.

Authors:  Albin Österroos; Tânia Maia; Anna Eriksson; Martin Jädersten; Vladimir Lazarevic; Lovisa Wennström; Petar Antunovic; Jörg Cammenga; Stefan Deneberg; Fryderyk Lorenz; Lars Möllgård; Bertil Uggla; Emma Ölander; Eliana Aguiar; Fernanda Trigo; Martin Höglund; Gunnar Juliusson; Sören Lehmann
Journal:  Haematologica       Date:  2022-07-01       Impact factor: 11.047

Review 4.  Drug Repurposing for the Treatment of Acute Myeloid Leukemia.

Authors:  Vibeke Andresen; Bjørn T Gjertsen
Journal:  Front Med (Lausanne)       Date:  2017-11-29

5.  Endothelial damage and a thin intercellular fibrin network promote haemorrhage in acute promyelocytic leukaemia.

Authors:  Chunxu Wang; Muxin Yu; Peng Zhou; Baorong Li; Yingmiao Liu; Lixiu Wang; Xiaojing Chen; Jingwen Du; Yufeng Wang; Jinming Zhang; Haijiao Jing; Yiming Feng; Yue Zhang; Yueyue Li; Zengxiang Dong; Shaohong Fang; Valerie A Novakovic; Jin Zhou; Jialan Shi
Journal:  EBioMedicine       Date:  2020-09-16       Impact factor: 8.143

6.  [Analysis of early death factors and prognosis of acute promyelocytic leukemia].

Authors:  Y X Wu; D P Wu; S N Chen; H Y Qiu; Y Han; C X Li; X Ma; A N Sun; X W Tang; X H Hu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-12-14

7.  t(15; 17) associated with primary myelofibrosis: a case report of an unusual clinical presentation and diagnostic dilemma.

Authors:  Kalyan Nadiminti; Margarida Silverman; Sharathkumar Bhagavathi; Praveen Vikas
Journal:  Onco Targets Ther       Date:  2019-07-11       Impact factor: 4.147

8.  Rate of differentiation syndrome in patients based on timing of initial all-trans retinoic acid administration.

Authors:  Mary Nauffal; Lillian Werner; Jian Ni; Richard M Stone; Daniel J DeAngelo; Anne M McDonnell
Journal:  Leuk Res Rep       Date:  2019-11-27

9.  Early mortality and survival improvements for adolescents and young adults with acute promyelocytic leukemia in California: an updated analysis.

Authors:  Renata Abrahão; Raul C Ribeiro; Marcio H Malogolowkin; Ted Wun; Theresa H M Keegan
Journal:  Haematologica       Date:  2022-03-01       Impact factor: 9.941

10.  Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study.

Authors:  Sabine Kayser; Richard F Schlenk; Delphine Lebon; Martin Carre; Katharina S Götze; Friedrich Stölzel; Ana Berceanu; Kerstin Schäfer-Eckart; Pierre Peterlin; Yosr Hicheri; Ramy Rahme; Emmanuel Raffoux; Fatiha Chermat; Stefan W Krause; Walter E Aulitzky; Sophie Rigaudeau; Richard Noppeney; Celine Berthon; Martin Görner; Edgar Jost; Philippe Carassou; Ulrich Keller; Corentin Orvain; Thorsten Braun; Colombe Saillard; Ali Arar; Volker Kunzmann; Mathieu Wemeau; Maike De Wit; Dirk Niemann; Caroline Bonmati; Carsten Schwänen; Julie Abraham; Ahmad Aljijakli; Stephanie Haiat; Alwin Krämer; Albrecht Reichle; Martina Gnadler; Christophe Willekens; Karsten Spiekermann; Wolfgang Hiddemann; Carsten Müller-Tidow; Christian Thiede; Christoph Röllig; Hubert Serve; Martin Bornhäuser; Claudia D Baldus; Eva Lengfelder; Pierre Fenaux; Uwe Platzbecker; Lionel Adès
Journal:  Haematologica       Date:  2021-12-01       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.